Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$555M |
| 2 |
Citigroup
C
|
+$407M |
| 3 |
Medtronic
MDT
|
+$401M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$392M |
| 5 |
Gilead Sciences
GILD
|
+$362M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.43B |
| 2 |
Amazon
AMZN
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$1.1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 5 |
Bank of America
BAC
|
+$726M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.02% |
| 2 | Healthcare | 2.92% |
| 3 | Consumer Discretionary | 2.17% |
| 4 | Financials | 2.1% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
10751
CALL
UroGen Pharma
URGN
$2.36B
| $124K | ﹤0.01% |
9,800
-15,200
| -61% | -$226K |
|
10752
PUT
iShares Residential and Multisector Real Estate ETF
REZ
$863M
| $124K | ﹤0.01% |
1,400
-1,200
| -46% | -$100K |
|
10753
Rush Enterprises Class A
RUSHA
$9.6B
| $124K | ﹤0.01% |
2,351
-124,269
| -98% | -$6.16M |
|
10754
PUT
Driven Brands
DRVN
$2.13B
| $124K | ﹤0.01% |
8,700
-18,300
| -68% | -$251K |
|
10755
US Global Investors
GROW
$39.4M
| $124K | ﹤0.01% |
48,053
+31,471
| +190% | +$81.5K |
|
10756
Northern Trust
NTRS
$35B
| $124K | ﹤0.01% |
1,377
-59,821
| -98% | -$5.23M |
|
10757
Evolution Petroleum
EPM
$135M
| $124K | ﹤0.01% |
23,289
-23,858
| -51% | -$126K |
|
|
AIM
10758
AIM ImmunoTech
AIM
$6.69M
| $124K | ﹤0.01% |
4,582
+3,601
| +367% | +$120K |
|
10759
PUT
iShares Micro-Cap ETF
IWC
$1.52B
| $123K | ﹤0.01% |
+1,000
| New | +$121K |
|
10760
PUT
Westlake Chemical Partners
WLKP
$765M
| $123K | ﹤0.01% |
5,500
+900
| +20% | +$20.4K |
|
|
VMEO
10761
CALL
DELISTED
Vimeo
VMEO
| $123K | ﹤0.01% |
24,400
-9,800
| -29% | -$44.5K |
|
|
EWCZ
10762
PUT
DELISTED
European Wax Center
EWCZ
| $123K | ﹤0.01% |
18,100
+16,300
| +906% | +$127K |
|
|
OBE
10763
Obsidian Energy
OBE
$712M
| $123K | ﹤0.01% |
+22,191
| New | +$149K |
|
10764
CALL
ProShares Short Financials
SEF
$12.9M
| $123K | ﹤0.01% |
3,225
-11,500
| -78% | -$457K |
|
10765
CALL
Amer Sports
AS
$19.1B
| $123K | ﹤0.01% |
7,700
+7,200
| +1,440% | +$92.1K |
|
10766
PUT
Immunome
IMNM
$3.09B
| $123K | ﹤0.01% |
8,400
-14,700
| -64% | -$209K |
|
10767
PUT
Acumen Pharmaceuticals
ABOS
$193M
| $123K | ﹤0.01% |
49,500
+17,000
| +52% | +$46.1K |
|
|
WAY
10768
PUT
Waystar Holding Corp
WAY
$4.75B
| $123K | ﹤0.01% |
+4,400
| New | +$109K |
|
10769
Aware
AWRE
$26.4M
| $123K | ﹤0.01% |
65,577
-10,347
| -14% | -$21.7K |
|
10770
CALL
Actinium Pharmaceuticals
ATNM
$32.6M
| $123K | ﹤0.01% |
65,200
+39,700
| +156% | +$157K |
|
10771
CALL
OFS Capital
OFS
$48.1M
| $123K | ﹤0.01% |
14,500
-3,300
| -19% | -$27.7K |
|
|
LOAN
10772
Manhattan Bridge Capital
LOAN
$47.1M
| $122K | ﹤0.01% |
21,956
-4,005
| -15% | -$21.1K |
|
10773
CALL
ProShares Short QQQ
PSQ
$636M
| $122K | ﹤0.01% |
3,100
-9,360
| -75% | -$386K |
|
10774
CALL
Clean Energy Fuels
CLNE
$403M
| $122K | ﹤0.01% |
39,300
+14,600
| +59% | +$41.4K |
|
|
CCC
10775
CCC Intelligent Solutions
CCC
$4.11B
| $122K | ﹤0.01% |
11,059
-3,891,845
| -100% | -$42M |
|
Similar funds
Ken Griffin's Q3 2024 Portfolio in Review
As of Q3 2024, Ken Griffin held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Ken Griffin's Q3 2024 filing shows 1,614 new, 6,434 increased, 5,866 reduced and 1,610 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Ken Griffin's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
- Ken Griffin added most to NVIDIA in Q3 2024, an estimated $555M increase.
- Ken Griffin's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
- Ken Griffin fully exited Domino's in Q3 2024, selling an estimated $186M.
- Ken Griffin's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
- Ken Griffin opened 1,614 new positions and closed 1,610 in Q3 2024.
- Ken Griffin's portfolio value rose 4.9% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.